Olumiant Lawsuit | Get the Right Lawyer

What is Olumiant?

Olumiant (baricitinib) is a prescription medicine used to treat adults with moderately to severely active rheumatoid arthritis (RA) who have tried at least 1 other medicine called a tumor necrosis factor (TNF) antagonist that did not work well enough or could not be tolerated. The drug was approved by the FDA on May 31, 2018.

Olumiant Labeling to Carry Warning for Heart Attack, Cancer, Blood Clots, Death

The FDA on September 1, 2021, announced that it was requiring revisions to the Boxed Warning (1) on Olumiant and 2 other similar Janus Kinase (JAK) inhibitor drugs, Xeljanz/Xeljanz XR (tofacitinib) and Rinvoq (upadacitinib), to include information about the risks of serious heart-related events, cancer, blood clots, and death.

“Based on the review of a large randomized safety clinical trial, the FDA has concluded there is an increased risk of serious heart-related events such as heart attack or stroke, cancer, blood clots, and death with the arthritis and ulcerative colitis medicines Xeljanz and Xeljanz XR,” FDA said. “The FDA is requiring new and updated warnings for two other arthritis medicines in the same drug class as Xeljanz, called Janus kinase (JAK) inhibitors, Olumiant and Rinvoq.”

Olumiant Side Effects

Serious side effects of Olumiant may include:

• Heart-related events
• Heart attack
• Stroke
• Cancer
• Blood clots
• Lymphoma
• Lung cancer
• Death

More moderate side effects of Olumiant may include:

• Upper respiratory tract infections (such as a cold or sinus infection)
• Nausea
• Cold sores
• Shingles

FDA Recommendation

If you are taking Olumiant, you should tell your health care professional if you are a current or past smoker, or have had a heart attack, other heart problems, stroke, or blood clots in the past as these may put you at higher risk for serious problems with the drug. You should seek emergency help right away if you have any symptoms that may signal a heart attack, stroke, or blood clot.

FAQs

Can I join a class action lawsuit if I was harmed by Olumiant?

Yes, if a class action lawsuit is underway, you may be eligible to join it if your circumstances are similar to those of other plaintiffs. Class action lawsuits allow multiple plaintiffs to combine their claims, which can strengthen the overall case.

How long does it typically take to resolve an Olumiant lawsuit?

The duration of an Olumiant lawsuit can vary depending on the complexity of the case, the number of plaintiffs, and whether the case goes to trial. It could take several months to several years to reach a settlement or verdict.

Can I file an individual lawsuit instead of joining a class action in the Olumiant case?

Yes, you can file an individual lawsuit if your case involves unique or severe circumstances that warrant individual attention. This approach may be more appropriate if your situation differs significantly from other potential plaintiffs in a class action.

What should I do if my claim related to Olumiant is denied?

If your claim is denied, consult with an attorney to explore further legal action. An attorney can help challenge the denial and pursue compensation through a lawsuit.

See all related cases on dangerous drugs lawsuits that we’ve taken on.

Get a Free Olumiant Lawsuit Evaluation With Our Lawyers

The Pharmaceutical Litigation Group at Schmidt & Clark, LLP law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Olumiant lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.

Free Case Evaluation: Again, if you were harmed by Olumiant side effects, you should contact Schmidt and Clark’s lawyers immediately. You may be entitled to a settlement by filing an Olumiant lawsuit and we can help.